Justin Goodwin Selected Research

Justin Goodwin Research Topics

5	Malaria 05/2024 - 07/2020
5	Neoplasms (Cancer) 01/2019 - 12/2016
2	COVID-19 10/2023 - 01/2021
2	Reinfection 01/2023 - 01/2023
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2019 - 01/2017
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2018 - 01/2017
1	Parasitemia 05/2024
1	Emerging Communicable Diseases (Emerging Infectious Diseases) 01/2021
1	Hypoxia (Hypoxemia) 01/2018
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2018
1	Lung Neoplasms (Lung Cancer) 01/2017
1	Adenocarcinoma of Lung 01/2017

4	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 01/2017
3	Lumefantrine Drug Combination Artemether (Coartem)FDA Link 05/2024 - 01/2023
3	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 10/2018 - 01/2017
1	Lumefantrine FDA Link 05/2024
1	Antimalarials (Antimalarial Agents)IBA 01/2023
1	artemisinin (artemisinine)IBA 01/2023
1	2- methyl- 3- (4- phenylpiperidino)propionohydroxamic acid hydrochloride (K 76)IBA 01/2023
1	VaccinesIBA 11/2022
1	ElementsIBA 01/2021
1	pyrimethamine drug combination fanasil (Fansidar)FDA Link 07/2020
1	Amodiaquine (Camoquin)FDA Link 07/2020
1	NADP (NADPH)IBA 01/2019
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2019
1	Pyruvate Dehydrogenase Acetyl-Transferring KinaseIBA 01/2018
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2018
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2018
1	Transcription Factors (Transcription Factor)IBA 12/2016
1	Oxygen (Dioxygen)IBA 12/2016